CDMOs are increasingly fielding inquiries from biopharma clients on how reliant they are on China for their raw materials, ...

In a late-night reversal, Pfizer's former CEO and CFO issued a statement saying they now support the company's existing ...

With a new presidential administration next year, FDA Principal Deputy Commissioner Namandjé Bumpus would be in line to lead ...

The Centers for Medicare and Medicaid Services on Wednesday published a list of 101 commonly used generic medicines that ...

While Medicare doesn't currently cover anti-obesity drugs, a new report from the Congressional Budget Office estimates that ...

The three major PBMs being sued by the FTC have filed motions to disqualify the Democratic commissioners who would rule on ...

The FDA handed down a second complete response letter to Zealand Pharma for its glucagon receptor agonist in an ultra-rare ...

Artificial intelligence has its Nobel Prize moment. On Tuesday, the Nobel Prize in Physics went to a pair of longtime AI ...

Clearside Biomedical reported positive results from a Phase 2b trial of its tyrosine kinase inhibitor in patients with wet ...

Purespring Therapeutics has reeled in £80 million ($105 million) to test two gene therapies in humans. The Sofinnova Partners ...

Concentra Biosciences, a shell company from Tang Capital, wants to buy another biotech that has found itself in a bind. Kevin ...

Thera, Richter, InnoCare and Scholar Rock: Crinetics prices $500M offering: The San Diego biotech upsized the offering by $100 million from $400 million. The biotech last month asked the FDA to ...